This is a England news story, published by Guardian.
For more England news, you can click here:
more England newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
varenicline. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest effects smokers news, smoking rates news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
nicotineGuardian
•
75% Informative
About 85,000 people a year in England will be offered the chance to use varenicline.
The once-a-day tablet is as effective as vapes at helping people to kick the habit.
The drug helps people to quit by reducing cravings for nicotine and ensuring it cannot affect the brain in its usual way.
Health service bosses hope its use will lead to 9,500 fewer smoking-related deaths.
VR Score
74
Informative language
71
Neutral language
53
Article tone
informal
Language
English
Language complexity
45
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links